Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;22(6):1444.
doi: 10.3892/etm.2021.10879. Epub 2021 Oct 14.

Overactive bladder: A review and update

Affiliations

Overactive bladder: A review and update

Ioan Scarneciu et al. Exp Ther Med. 2021 Dec.

Abstract

Overactive bladder syndrome is a chronic, disabling condition with physical, psychological and social consequences that significantly affects the quality of life of millions of patients worldwide. The economic impact of this disorder is crucial. Overactive bladder syndrome is a little-known condition, with different manifestations from patient to patient, which causes a great deal of frustration to the medical staff involved. The patient requires a clear explanation and the full support of the attending physician. It is extremely important to establish a correct diagnosis and an effective individualized treatment. The collaboration and understanding of these patients are extremely important aspects. Improving the quality of life in these patients is the main purpose in managing this condition. There are several treatment modalities that may be used progressively, with favorable albeit inconsistent results. This condition remains extremely challenging for specialists and, unfortunately, always one of maximum interest.

Keywords: analysis; antimuscarinic drugs; augmentation cystoplasty; intravesical botulinum toxin A; overactive bladder; posterior tibial nerve stimulation; quality of life; sacral neuromodulation; treatment; β3-agonists.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Leron E, Weintraub AY, Mastrolia SA, Schwarzman P. Overactive bladder syndrome: Evaluation and management. Curr Urol. 2018;11:117–125. doi: 10.1159/000447205. - DOI - PMC - PubMed
    1. Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000;6 (Suppl):S580–S590. - PubMed
    1. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760–766. doi: 10.1046/j.1464-410x.2001.02228.x. - DOI - PubMed
    1. Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, Chapple C. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: Results from EpiLUTS. BJU Int. 2011;108:1459–1471. doi: 10.1111/j.1464-410X.2010.10013.x. - DOI - PubMed
    1. Donaldson MM, Thompson JR, Matthews RJ, Dallosso HM, McGrother CW. The natural history of overactive bladder and stress urinary incontinence in older women in the community: A 3-year prospective cohort study. Neurourol Urodyn. 2006;25:709–716. doi: 10.1002/nau.20235. Leicestershire MRC Incontinence Study Group. - DOI - PubMed